Report Detail
Global (United States, European Union and China) Tinea Pedis Treatment Market Research Report 2019-2025
- RnM3635673 |
- 30 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes.
The rising prevalence of diabetes that is fueling the incidence of tinea pedis is one of the primary growth factors for this market. There is an increased prevalence of diabetes across the globe due to high levels of sugar in the blood streams and this results in numerous health issues. Diabetes reduces the quality of life, increases the risk of obesity, and early death. People with diabetes tend to be more resistant to antifungal treatment regimens due to high blood glucose levels which increases the chances of fungal growth. Consequently, diabetes patients tend to have a high risk of foot ulcerations and infections that can lead to tinea pedis or onychomycosis resulting in the need for the effective treatment of this infection.
North America is the largest and reflects a high market attractiveness index. APEJ is the second largest regional market for tinea pedis treatment in terms of valuation and is the fastest growing region with a high CAGR of 6.1% recorded during the period of forecast.
In 2019, the market size of Tinea Pedis Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tinea Pedis Treatment.
This report studies the global market size of Tinea Pedis Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tinea Pedis Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GSK
Exeltis USA
Valeant
Incyte
Celgene
Hisamitsu Pharmaceutical
NovaBiotics
Elorac
F. Hoffmann-La Roche
Sanofi
Teva Pharmaceutical
Market Segment by Product Type
Interdigital
Vesicular
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Tinea Pedis Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tinea Pedis Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Tinea Pedis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Tinea Pedis Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Interdigital
- 1.3.3 Vesicular
- 1.4 Market Segment by Application
- 1.4.1 Global Tinea Pedis Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.4.5 Drug Stores
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Tinea Pedis Treatment Market Size
- 2.1.1 Global Tinea Pedis Treatment Revenue 2014-2025
- 2.1.2 Global Tinea Pedis Treatment Sales 2014-2025
- 2.2 Tinea Pedis Treatment Growth Rate by Regions
- 2.2.1 Global Tinea Pedis Treatment Sales by Regions 2014-2019
- 2.2.2 Global Tinea Pedis Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Tinea Pedis Treatment Sales by Manufacturers
- 3.1.1 Tinea Pedis Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Tinea Pedis Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Tinea Pedis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Tinea Pedis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Tinea Pedis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Tinea Pedis Treatment Price by Manufacturers
- 3.4 Key Manufacturers Tinea Pedis Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Tinea Pedis Treatment Market
- 3.6 Key Manufacturers Tinea Pedis Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Interdigital Sales and Revenue (2014-2019)
- 4.1.2 Vesicular Sales and Revenue (2014-2019)
- 4.2 Global Tinea Pedis Treatment Sales Market Share by Type
- 4.3 Global Tinea Pedis Treatment Revenue Market Share by Type
- 4.4 Tinea Pedis Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Tinea Pedis Treatment Sales by Application
6 United States
- 6.1 United States Tinea Pedis Treatment Breakdown Data by Company
- 6.2 United States Tinea Pedis Treatment Breakdown Data by Type
- 6.3 United States Tinea Pedis Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Tinea Pedis Treatment Breakdown Data by Company
- 7.2 European Union Tinea Pedis Treatment Breakdown Data by Type
- 7.3 European Union Tinea Pedis Treatment Breakdown Data by Application
8 China
- 8.1 China Tinea Pedis Treatment Breakdown Data by Company
- 8.2 China Tinea Pedis Treatment Breakdown Data by Type
- 8.3 China Tinea Pedis Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Tinea Pedis Treatment Breakdown Data by Company
- 9.2 Rest of World Tinea Pedis Treatment Breakdown Data by Type
- 9.3 Rest of World Tinea Pedis Treatment Breakdown Data by Application
- 9.4 Rest of World Tinea Pedis Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Tinea Pedis Treatment Sales by Countries
- 9.4.2 Rest of World Tinea Pedis Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GSK
- 10.1.1 GSK Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.1.4 Tinea Pedis Treatment Product Introduction
- 10.1.5 GSK Recent Development
- 10.2 Exeltis USA
- 10.2.1 Exeltis USA Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.2.4 Tinea Pedis Treatment Product Introduction
- 10.2.5 Exeltis USA Recent Development
- 10.3 Valeant
- 10.3.1 Valeant Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.3.4 Tinea Pedis Treatment Product Introduction
- 10.3.5 Valeant Recent Development
- 10.4 Incyte
- 10.4.1 Incyte Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.4.4 Tinea Pedis Treatment Product Introduction
- 10.4.5 Incyte Recent Development
- 10.5 Celgene
- 10.5.1 Celgene Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.5.4 Tinea Pedis Treatment Product Introduction
- 10.5.5 Celgene Recent Development
- 10.6 Hisamitsu Pharmaceutical
- 10.6.1 Hisamitsu Pharmaceutical Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.6.4 Tinea Pedis Treatment Product Introduction
- 10.6.5 Hisamitsu Pharmaceutical Recent Development
- 10.7 NovaBiotics
- 10.7.1 NovaBiotics Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.7.4 Tinea Pedis Treatment Product Introduction
- 10.7.5 NovaBiotics Recent Development
- 10.8 Elorac
- 10.8.1 Elorac Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.8.4 Tinea Pedis Treatment Product Introduction
- 10.8.5 Elorac Recent Development
- 10.9 F. Hoffmann-La Roche
- 10.9.1 F. Hoffmann-La Roche Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.9.4 Tinea Pedis Treatment Product Introduction
- 10.9.5 F. Hoffmann-La Roche Recent Development
- 10.10 Sanofi
- 10.10.1 Sanofi Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Tinea Pedis Treatment
- 10.10.4 Tinea Pedis Treatment Product Introduction
- 10.10.5 Sanofi Recent Development
- 10.11 Teva Pharmaceutical
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Tinea Pedis Treatment Sales Channels
- 11.2.2 Tinea Pedis Treatment Distributors
- 11.3 Tinea Pedis Treatment Customers
12 Market Forecast
- 12.1 Global Tinea Pedis Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Tinea Pedis Treatment Sales Forecast by Type
- 12.3 Global Tinea Pedis Treatment Sales Forecast by Application
- 12.4 Tinea Pedis Treatment Forecast by Regions
- 12.4.1 Global Tinea Pedis Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Tinea Pedis Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Tinea Pedis Treatment. Industry analysis & Market Report on Tinea Pedis Treatment is a syndicated market report, published as Global (United States, European Union and China) Tinea Pedis Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Tinea Pedis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
